-transparent.png){kind=logo}
We recently reported that interleukin-12 (IL-12) stimulated hepatic NK1.1 Ag+ alpha beta T cells with intermediate T-cell receptor (TCR; NK1+ TCRint cells) and enhanced their NK1 expression (NK1high TCRint), and that these cells acquire strong major histocompatibility complex (MHC) unrestricted cytotoxicity in C57BL/6 mice, both +/+ and nu/nu. In the present study, we find that although murine lung normally has few NK1+ TCRint cells, NK1high TCRint cells are induced in+/+ and nu/nu mice after systemic administration of IL-12; these cells exhibit strong MHC unrestricted cytotoxicity against NK-sensitive and -resistant targets. A small number of NK1high TCRint cells was also found in peripheral blood after increased amounts of IL-12 were administered. Cytotoxicity tests in vitro revealed that the cytotoxic activity of the lung mononuclear cells (MNC) of C57BL/6 mice induced by IL-12 was abrogated by the depletion of either NK1+ or CD3+ cells, but not of CD8+ cells, as reportedly was the case of hepatic MNC, suggesting that NK1high TCRint cells are an antimetastatic population not only in the liver but also in the lung of mice. IL-12 injection into mice markedly elevates serum interferon-gamma (IFN-gamma) levels. However, although IL-12-induced cytotoxicity of NK1high TCRint cells was significantly reduced by anti-IFN-gamma antibody injection (which decreased serum IFN-gamma to an undetectable level), the appearance of NK1high TCRint cells in the lung and liver was not so affected. These results suggest that IFN-gamma is an important mediator of the cytotoxicity of NK1high TCRint cells but is not an essential factor for induction of these cells. We also added data showing that IL-12 has a broad antimetastatic effect against various liver and lung metastatic tumours intravenously injected into several strains of mice, including NK-deficient bg/bg mice. It can be considered that, in addition to NK cells, CD8+ cytotoxic T cells and gamma delta T cells, NK1+ TCRint cells can be categorized as one of the cytotoxic effector populations. These novel type cells distinct from regular T cells may play an important role in monitoring intra- and perivascular areas.
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
September 1980,
The Journal of experimental medicine,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
January 2001,
Advances in experimental medicine and biology,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
August 1994,
Immunopharmacology and immunotoxicology,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
June 1996,
International archives of allergy and immunology,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
January 1975,
Folia biologica,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
September 1983,
Infection and immunity,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
August 1995,
Scandinavian journal of immunology,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
October 1996,
The Journal of experimental medicine,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
August 1999,
Blood,
R Anzai, and
S Seki, and
K Ogasawara, and
W Hashimoto, and
K Sugiura, and
M Sato, and
K Kumagai, and
K Takeda
August 1986,
Infection and immunity,
